Skip to content

Placebo Effect: Immune Mechanisms and Clinical Evidence Explained

Discover how the placebo effect activates brain chemicals like dopamine and endorphins, reducing pain and improving health through neurobiological mechanisms.

Estimated reading time: 6 minutes

Your mind holds a powerful pharmacy. This concept is not just a metaphor. Rigorous scientific studies now prove this reality. The placebo effect harnesses the brain’s own chemistry. A recent study by Prossin and colleagues explored this mechanism. They investigated the link between immune responses and brain signals. Their work, published in Molecular Psychiatry, focused on endogenous opioid neurotransmission. These are the body’s natural painkillers. Separate clinical observations reinforce these findings. Atasoy’s 2020 review summarizes the clinical evidence clearly. Together, this research shifts our understanding. The placebo effect is a measurable biological event. It coordinates neural and immune system activity. This knowledge opens new paths for holistic, patient-centred care.

Key Takeaways: Placebo Effect

  • A placebo triggers real biological changes via specific brain pathways.
  • Endogenous opioid release directly mediates immune system modifications during placebo responses.
  • Positive expectation alone can measurably reduce inflammation in the body.
  • Genuine healing responses operate through neuro-immune communication networks.
  • Effective patient care benefits greatly from harnessing this mind-body connection.

The Biology of the Placebo Effect

Biology of the Placebo Effect
Fig. 1: Expectations may link brain and immunity

The traditional view treats placebos as simple deception. However, research now describes placebo effects as psychobiological responses shaped by expectation, learning, and context. When someone expects relief, brain systems involved in pain regulation may become active. In turn, those systems can influence how pain is experienced and how the body responds.

Endogenous Opioids and Brain Activity

The body produces its own opioid molecules, called endogenous opioids. These compounds help regulate pain and other functions. For example, Prossin and colleagues’ 2022 study used PET imaging to examine brain μ-opioid receptors during a placebo intervention given with the expectation of pain relief. The study also measured the inflammatory signaling protein IL-18 in the blood. Its findings linked placebo-related brain opioid activity with changes in IL-18, suggesting a connection between pain expectation and immune signalling. However, the results do not establish that placebos directly suppress inflammation throughout the body.

More broadly, opioid receptors and signaling pathways are found in both the nervous and immune systems. Therefore, researchers are investigating how these systems interact. Still, the effects can vary depending on the context and the specific immune signals involved. Rather than showing that psychological and physical processes are interchangeable, placebo research illustrates how brain activity can influence bodily experience and may interact with physiological processes.

How Expectation May Influence Immune Signaling

To investigate this connection, Prossin and colleagues studied participants under conditions involving expected pain relief. They compared PET measures of brain opioid activity with blood levels of IL-18, a protein involved in inflammation and pain. The results suggested an association between placebo-related opioid activity and IL-18. In other words, the study offers evidence of a possible brain–immune link, but it does not show that verbal suggestions alone reliably reduce immune activity or treat inflammatory disease.

Finally, this research contributes to psychoneuroimmunology—the study of interactions among psychological processes, the nervous system, and the immune system. Although expectation and context can shape bodily responses, the underlying pathways are complex. Further research is needed to determine when these effects occur and what they mean for clinical care.

Clinical Evidence from Open-Label Placebo Research

Some people assume that placebos only work when patients are unaware they are receiving them. However, open-label placebo research tests a different approach: patients are told that the treatment is a placebo. Studies have reported potential benefits in certain conditions, including irritable bowel syndrome and chronic low back pain. Still, results vary, and open-label placebos are not established treatments for every condition.

The Role of the Therapeutic Ritual

In an open-label approach, a clinician explains that the pill contains no active drug and describes how expectations, learning, and the treatment context may influence symptoms. The pill-taking ritual and supportive clinical relationship may contribute to a patient’s experience. However, researchers are still investigating the mechanisms, and it would be too strong to say that the ritual reliably activates a specific healing pathway or directly suppresses inflammation.

Moreover, the therapeutic encounter involves more than the pill itself. Clear communication, empathy, and trust can support care and shape patients’ expectations. These factors may influence symptoms, particularly pain, but they should complement—not replace—appropriate medical evaluation and treatment.

Patient-Reported Outcomes and Chronic Conditions

Open-label placebos have been studied for conditions such as irritable bowel syndrome and chronic low back pain. In some trials, participants who knew they were taking a placebo reported symptom improvement. Nevertheless, reported relief does not by itself establish a cure or demonstrate that the underlying condition has changed.

For chronic pain, that distinction matters: a change in pain can be meaningful even if the underlying cause remains. At the same time, findings are not uniform, and benefits may not persist. For example, a three-year follow-up of a chronic low back pain trial found no lasting differences between participants who had received open-label placebos and those who had not.

Therefore, open-label placebos may be worth studying as a possible adjunct to care, but they should not be presented as a guaranteed, side-effect-free treatment or a substitute for established therapies.

Frequently Asked Questions (FAQs): Placebo Effect

What makes the placebo effect work in your body?

Your brain acts like a master conductor, orchestrating chemicals like dopamine and endorphins to reduce pain and boost mood. It even trains your immune system to mimic drug effects through learned responses. Think of it as your body’s built-in pharmacy, activated by belief and expectation

Can a placebo really affect your immune system?

Yes! Your immune system can learn through association. For example, pairing a flavored drink with an immunosuppressive drug can train your body to react to the flavor alone. As a matter of fact, it’s like Pavlov’s dog, but instead of salivating, your immune system adjusts its response.

Are placebo effects just “in your head”?

Not at all! Placebos trigger real biological changes. Your brain releases chemicals that reduce pain, improve mood, and even regulate your immune system. It’s like flipping a switch that activates your body’s self-healing powers.

Can the placebo effect replace real medicine?

No, but it can complement it. Placebos work best for conditions like pain or stress, where your brain’s natural chemicals play a big role. They’re not a substitute for treatments like antibiotics or cancer therapies, but they can enhance overall care.

Refrences

Prossin, A., Koch, A., Campbell, P. et al. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Mol Psychiatry 27, 831–839 (2022). https://doi.org/10.1038/s41380-021-01365-x

Atasoy, Ö. (2020). The placebo effect. Demiroglu Science University Florence Nightingale Journal of Medicine, 6(3), 124–128. https://doi.org/10.5606/fng.btd.2020.25033

Disclaimer.